Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.59 |
| ▸ | CA1 | P00915 | 4/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.41 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | XBP1 | P17861 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL535672 | 1.00 | CA2 (0.59) | CA2CA1MAPK1ZDHHC7FAAH | |
| SCHEMBL1274961 | 1.00 | CA2 (0.59) | CA2CA1MAPK1ZDHHC7FAAH | |
| SCHEMBL28899012 | 1.00 | CA2 (0.59) | CA2CA1MAPK1ZDHHC7FAAH | |
| SCHEMBL866148 | 1.00 | CA2 (0.59) | CA2CA1MAPK1ZDHHC7FAAH | |
| SCHEMBL22471739 | 0.98 | CA2 (0.56) | CA2CA1MAPK1ZDHHC7FAAH | |
| 2-Ethylhexanoic Acid SCHEMBL9543013 | 0.94 | CA2 (0.62) | CA2CA1MAPK1GRIK1GRIK2 | |
| Ether SCHEMBL3957556 | 0.94 | CA2 (0.53) | CA2CA1MAPK1ZDHHC7FAAH | |
| SCHEMBL2304371 | 0.93 | CA2 (0.55) | CA2CA1MAPK1ZDHHC7FAAH | |
| SCHEMBL473755 | 0.93 | CA2 (0.59) | CA2CA1MAPK1ZDHHC7FAAH | |
| SCHEMBL2305289 | 0.93 | CA2 (0.55) | CA2CA1MAPK1ZDHHC7FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119015394-A | Sulfur-containing compound preparation, and preparation method and application thereof | 上海优斐斯生物科技有限公司 | 2024-11-26 | — | — | CN | claimed |
| CN-119015394-A | Sulfur-containing compound preparation, and preparation method and application thereof | 上海优斐斯生物科技有限公司 | 2024-11-26 | — | — | CN | disclosed |
| US-11234905-B2 | Formulations having improved compatibility with nonwoven substrates | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2022-02-01 | — | — | US | disclosed |
| US-10307351-B2 | Substrates having formulations with improved transferability | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2019-06-04 | — | — | US | disclosed |
| EP-2309972-B1 | SUBSTRATES HAVING FORMULATIONS WITH IMPROVED TRANSFERABILITY | KIMBERLY CLARK CO (US) | 2018-10-24 | — | — | EP | disclosed |
| US-20180200168-A1 | SUBSTRATES HAVING FORMULATIONS WITH IMPROVED TRANSFERABILITY | KIMBERLY-CLARK WORLDWIDE, INC. | 2018-07-19 | — | — | US | disclosed |
| US-9949906-B2 | Substrates having formulations with improved transferability | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2018-04-24 | — | — | US | disclosed |
| EP-2309971-B1 | FORMULATIONS HAVING IMPROVED COMPATIBILITY WITH NONWOVEN SUBSTRATES | KIMBERLY CLARK CO (US) | 2015-10-07 | — | — | EP | disclosed |
| US-8790710-B1 | Topical composition comprising umbilical cord blood serum | Novo Solutions, MD, L.L.C. (US) | 2014-07-29 | — | — | US | disclosed |
| US-20120093896-A1 | USE OF NANODISPERSIONS TO PROTECT WATER-SOLUBLE INGREDIENTS IN COSMETIC END FORMULATIONS | CIBA CORPORATION (US) | 2012-04-19 | — | — | US | disclosed |
| WO-2010004519-A2 | SUBSTRATES HAVING FORMULATIONS WITH IMPROVED TRANSFERABILITY | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2010-01-14 | — | — | WO | disclosed |
| WO-2010004518-A2 | FORMULATIONS HAVING IMPROVED COMPATIBILITY WITH NONWOVEN SUBSTRATES | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2010-01-14 | — | — | WO | disclosed |
| WO-2010001293-A2 | SPRAYABLE SKIN PROTECTANT FORMULATION AND METHOD OF USE | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2010-01-07 | — | — | WO | disclosed |
| US-20090324506-A1 | Sprayable skin protectant formulation and method of use | KIMBERLY-CLARK WORLDWIDE, INC. | 2009-12-31 | — | — | US | disclosed |
| EP-2099530-A1 | UV ABSORBER FORMULATIONS | Ciba Holding Inc. (CH) | 2009-09-16 | — | — | EP | disclosed |
| US-20090196894-A1 | Self Tanning Composition | CIBA CORP. | 2009-08-06 | — | — | US | disclosed |
| EP-2026746-A2 | SELF TANNING COMPOSITION | Ciba Holding Inc. (CH) | 2009-02-25 | — | — | EP | disclosed |
| WO-2009016064-A1 | USE OF NANODISPERSIONS TO PROTECT WATER-SOLUBLE INGREDIENTS IN COSMETIC END FORMULATIONS | BASF SE (CH) | 2009-02-05 | — | — | WO | disclosed |
| WO-2008080892-A1 | UV ABSORBER FORMULATIONS | CIBA HOLDING INC. (CH) | 2008-07-10 | — | — | WO | disclosed |
| WO-2007137958-A2 | SELF TANNING COMPOSITION | CIBA HOLDING INC. (CH) | 2007-12-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090196894-A1 | Self Tanning Composition | C9, KRT18, F12 | CA2 4251/4885CA1 4188/4885MAPK1 2268/4885 |
| US-20120093896-A1 | USE OF NANODISPERSIONS TO PROTECT WATER-SOLUBLE INGREDIENTS IN COSMETIC END FORMULATIONS | CUTA, PROC, RBP1 | CA2 2253/4885CA1 4037/4885MAPK1 3461/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.